Grantham, Mayo, Van Otterloo & Co (GMO)
IPHS

Grantham, Mayo, Van Otterloo & Co (GMO)’s Innophos Holdings, Inc. IPHS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio IPHS Stock Details IPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,300
Closed -$521K – 854
2019
Q4 		$521K Sell
16,300
-3,200
-16% -$103K ﹤0.01% 591
2019
Q3 		$633K Buy
+19,500
New +$562K ﹤0.01% 603
2017
Q4 		– Sell
-4,200
Closed -$207K – 649
2017
Q3 		$207K Buy
+4,200
New +$189K ﹤0.01% 537
2017
Q2 		– Sell
-4,200
Closed -$227K – 647
2017
Q1 		$227K Buy
+4,200
New +$217K ﹤0.01% 514

Other funds holding IPHS

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s IPHS Position: Q1 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 16,300 shares — an estimated $521K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IPHS in Q1 2017 and held it in 4 quarters. The position peaked at $633K in Q3 2019. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 16,300 Innophos Holdings, Inc. shares in Q1 2020, an estimated $521K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Innophos Holdings, Inc. in Q1 2017 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Innophos Holdings, Inc. position peaked at $633K in Q3 2019.
  • 2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2020, filed 14 May 2020.